Understanding OUR Cytokine-Based Immunotherapy Candidates Our dedication extends to advancing a robust portfolio of programs geared toward expanding the horizons of cytokine-based immunotherapy, especially for cancers where therapy alternatives remain limited. Use the links below to learn much more about our portfolio of cytokine-based immunotherapy candidates. Take a look https://financefeeds.com/avaxai-builds-first-deepseek-powered-defai-product/